Seth Rudnick Net Worth & Insider Trades

Seth Rudnick - Director, Aralez Pharmaceuticals Inc

As of May 12, 2017

What is Seth Rudnick's Net Worth?

The current estimated net worth of Aralez Pharmaceuticals Inc's Director, Seth Rudnick, is estimated to be about $31.48M . Seth Rudnick owns about 109,391 units of Aralez Pharmaceuticals Inc common stock. In the last year at Aralez Pharmaceuticals Inc, Seth Rudnick has sold an estimated value of $0 worth.

What is Seth Rudnick's Past Insider Trading?

Seth Rudnick's largest purchase order was 30,000 units , worth over $143.12K on November 15, 2016. In total, Seth Rudnick has made about 6 transactions over a year of their time at Aralez Pharmaceuticals Inc. Seth Rudnick usually trades in March, June, February, November, December and May, with the busiest year in 2016. The most recent transaction was a purchase order of 15,000 units , worth over $33.95K on March 17, 2017.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Seth Rudnick's' Mailing Address?

  • Mailing address is 7100 West Credit Avenue, Suite 101 C/o Aralez Pharmaceuticals Mississauga A6 L5N 0E4 Ontario, Canada

What are Aralez Pharmaceuticals Inc's Past Insider Trades?

Aralez Pharmaceuticals Inc's most recent insider trade came on June 6, 2018 by Andrew I Koven who sold 156,573 units worth $58.59K . In the last 2 years, insiders at Aralez Pharmaceuticals Inc have sold an estimated value of $18.43M and bought an estimated value of $4.72M worth of shares. Insider trading is most common in May, with the busiest year in 2016. The most active traders at the company are Andrew I Koven, President & Chief Business Off,  James P. Tursi, Chief Medical Officer,  and Arthur S Kirsch, Director .

Aralez Pharmaceuticals Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1